THE HUMAN EOSINOPHIL CHARCOT-LEYDEN CRYSTAL PROTEIN: BIOCHEMICAL CHARACTERISTICS AND MEASUREMENT BY RADIOIMMUNOASSAYACKERMAN SJ; LOEGERING DA; GLEICH GJ et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2118-2126; BIBL. 34 REF.Article

AN IMMUNOFLUORESCENT METHOD FOR SPECIFIC STAINING OF EOSINOPHIL GRANULE MAJOR BASIC PROTEINFILLEY WV; ACKERMAN SJ; GLEICH GJ et al.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 47; NO 2; PP. 227-238; BIBL. 21 REF.Article

FORMATION OF CHARCOT-LEYDEN CRYSTALS BY HUMAN BASOPHILSACKERMAN SJ; WEIL GJ; GLEICH GJ et al.1982; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1982; VOL. 155; NO 6; PP. 1597-1609; BIBL. 18 REF.Article

PURIFICATION OF HUMAN EOSINOPHIL-DERIVED NEUROTOXINDURACK DT; ACKERMAN SJ; LOEGERING DA et al.1981; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; ISSN 0273-1134; USA; DA. 1981; VOL. 78; NO 8; PP. 5165-5169; BIBL. 27 REF.Article

EOSINOPHIL GRANULE MAJOR BASIC PROTEIN AND CHARCOT-LEYDEN CRYSTAL PROTEIN IN HUMAN TEARSUDELL IJ; GLEICH GJ; ALLANSMITH MR et al.1981; AM. J. OPHTHALMOL.; ISSN 0002-9394; USA; DA. 1981; VOL. 92; NO 6; PP. 824-828; BIBL. 24 REF.Article

ADVERSE EFFECTS OF PHENOBARBITAL ON CORTICOSTEROID METABOLISM IN PATIENTS WITH BRONCHIAL ASTHMA = EFFETS SECONDAIRES DU PHENOBARBITAL SUR LE METABOLISME DES CORTICOIDES CHEZ DES MALADES ATTEINTS D'ASTHME BRONCHIQUEBROOKS SM; WERK EE; ACKERMAN SJ et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 286; NO 21; PP. 1125-1128; BIBL. 16 REF.Serial Issue